Literature DB >> 10919637

A genome-wide map showing common regions of loss of heterozygosity/allelic imbalance in breast cancer.

R J Osborne1, M G Hamshere.   

Abstract

We report here a new framework map that integrates data from 143 studies on the loss of heterozygosity/allelic imbalance in breast cancer. Full details of these loss of heterozygosity maps can be found at the web site (http://www.nottingham.ac.uk/pdzmgh/loh/) that accompanies this report. By combining results from these data, we have also been able to highlight and identify minimum commonly deleted regions on each chromosome. In addition to finding commonly deleted regions at both the BRCA1 and BRCA2 loci, which confirmed the power of the technique, 24 other regions were identified on 16 different chromosomes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10919637

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  25 in total

1.  Single nucleotide polymorphism array analysis of flow-sorted epithelial cells from frozen versus fixed tissues for whole genome analysis of allelic loss in breast cancer.

Authors:  Elizabeth L Schubert; Li Hsu; Laura A Cousens; Jeri Glogovac; Steve Self; Brian J Reid; Peter S Rabinovitch; Peggy L Porter
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

2.  Predictive pharmacogenetic biomarkers for breast cancer recurrence prevention by simvastatin.

Authors:  Thomas P Ahern; Per Damkier; Søren Feddersen; Anders Kjærsgaard; Timothy L Lash; Stephen Hamilton-Dutoit; Cathrine Bredal Lythjohan; Bent Ejlertsen; Peer M Christiansen; Deirdre P Cronin-Fenton
Journal:  Acta Oncol       Date:  2020-04-30       Impact factor: 4.089

3.  Whole genome amplification of plasma-circulating DNA enables expanded screening for allelic imbalance in plasma.

Authors:  Jin Li; Lyndsay Harris; Harvey Mamon; Matthew H Kulke; Wei-Hua Liu; Penny Zhu; G Mike Makrigiorgos
Journal:  J Mol Diagn       Date:  2006-02       Impact factor: 5.568

4.  High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss.

Authors:  A Maitra; I I Wistuba; C Washington; A K Virmani; R Ashfaq; S Milchgrub; A F Gazdar; J D Minna
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

5.  Identification of Fat4 as a candidate tumor suppressor gene in breast cancers.

Authors:  Chao Qi; Yiwei Tony Zhu; Liping Hu; Yi-Jun Zhu
Journal:  Int J Cancer       Date:  2009-02-15       Impact factor: 7.396

Review 6.  Gene therapy for carcinoma of the breast.

Authors:  M A Stoff-Khalili; P Dall; D T Curiel
Journal:  Cancer Gene Ther       Date:  2006-01-06       Impact factor: 5.987

7.  Genome-wide linkage scan for prostate cancer susceptibility in Finland: evidence for a novel locus on 2q37.3 and confirmation of signal on 17q21-q22.

Authors:  Cheryl D Cropp; Claire L Simpson; Tiina Wahlfors; Nati Ha; Asha George; MaryPat S Jones; Ursula Harper; Damaris Ponciano-Jackson; Tiffany A Green; Teuvo L J Tammela; Joan Bailey-Wilson; Johanna Schleutker
Journal:  Int J Cancer       Date:  2011-04-20       Impact factor: 7.396

8.  Concordance of metabolic enzyme genotypes assayed from paraffin-embedded, formalin-fixed breast tumors and normal lymphatic tissue.

Authors:  Thomas P Ahern; Mariann Christensen; Deirdre P Cronin-Fenton; Kathryn L Lunetta; Carol L Rosenberg; Henrik Toft Sørensen; Timothy L Lash; Stephen Hamilton-Dutoit
Journal:  Clin Epidemiol       Date:  2010-10-22       Impact factor: 4.790

9.  Loss of heterozygosity or allele imbalance in histologically normal breast epithelium is distinct from loss of heterozygosity or allele imbalance in co-existing carcinomas.

Authors:  Pamela S Larson; Antonio de las Morenas; Sheila R Bennett; L Adrienne Cupples; Carol L Rosenberg
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

10.  A mammary-specific, long-range deletion on mouse chromosome 11 accelerates Brca1-associated mammary tumorigenesis.

Authors:  Aleata A Triplett; Cristina Montagna; Kay-Uwe Wagner
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.